Find out why doing the Mind Screen early is the key to getting your patients better sooner.
Find out why the Mind Screen is superior to single-disorder assessment tools.
Find out what the Mind Screen includes.
Find out how to use the Mind Screen in your daily work flow.
Find out how using the Mind Screen will benefit you and your practice.
Find out what real practitioners and patients think of the Mind Screen.
Find out why doing the Mind Screen is the key to getting better sooner.
Find out why you will never go back to using single-disorder assessment tools.
Find out what you get when you do a Mind Screen.
Find out what to expect when doing a Mind Screen.
Find out what others say about the Mind Screen.
Find out about the 30+ conditions assessed by the Mind Screen.
Find out why doing the Mind Screen early is the key to getting better and back to work sooner.
Find out why the Mind Screen is simply better than single-disorder assessment tools.
Find out how the Mind Screen will increase productivity and reduce costs at your workplace.
Find out why the Mind Screen EAP+ Workplace Program beats traditional EAP programs hands down.
Adult ADHD may affect 30% of people who had ADHD in childhood.
1 DSM-IV-TR workgroup. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association.
12 The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. Archives of General Psychiatry, 1999; 56:1073-1086.
15 Wilens TE, Biederman J, Spencer TJ. Attention deficit/hyperactivity disorder across the lifespan. Annual Review of Medicine, 2002; 53:113-131.
16 Coghill D, Seth S. Osmotic, controlled-release methylphenidate for the treatment of attention-deficit/hyperactivity disorder. Expert Opinions in Pharmacotherapy, 2006 Oct; 7(15):2119-2138.
17 Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study. Biological Psychiatry, 2005 Apr 1; 57(7):793-801.
Share this page